Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation. (2022)

First Author: Kennedy A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41590-022-01289-w

PubMed Identifier: 35999394

Publication URI: http://europepmc.org/abstract/MED/35999394

Type: Journal Article/Review

Volume: 23

Parent Publication: Nature immunology

Issue: 9

ISSN: 1529-2908